Literature DB >> 26200841

Invasion phenotypes of oral squamous cell carcinoma.

Shahroo Etemad-Moghadam1, Mojgan Alaeddini.   

Abstract

The invasion signature of tumor cells can strongly affect their metastatic behavior; therefore, we aimed to evaluate the different invasion phenotypes of oral squamous cell carcinoma (OSCC) and to determine the correlation of these markers with neoplastic mode of invasion. A total of 92 OSCCs were graded according to the Yamamoto criteria and subjected to immunohistochemistry using monoclonal antibodies against E-cadherin, N-cadherin, and podoplanin. Samples were grouped into epithelial-mesenchymal transition (EMT), collective-cell invasion (CCI), and combined intermediate phenotypes followed by statistical analysis. Significant differences were found among the 3 groups (P<0.001), between EMT and CCI (P=0.023) and between the combined phenotypes and both EMT and CCI, separately (P<0.001). Mode of invasion was significantly associated with E-cadherin (P=0.022), but not the other markers. There seems to be a preference for OSCCs to migrate by CCI; however, most our samples showed an intermediate phenotype between EMT and CCI, which confirm the existence of a spectrum of migration signatures that need to be further evaluated in these tumors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26200841     DOI: 10.1097/PAI.0000000000000184

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  3 in total

1.  Correlation between invasion mode and the histologic risk assessment model in oral squamous cell carcinoma.

Authors:  Mojgan Alaeddini; Shahroo Etemad-Moghadam
Journal:  Oral Maxillofac Surg       Date:  2016-08-09

2.  Pattern of invasion in squamous cell carcinomas of the lower lip and oral cavity.

Authors:  Shahroo Etemad-Moghadam; Mojgan Alaeddini
Journal:  J Oral Biol Craniofac Res       Date:  2017-05-05

3.  Telomerase reverse transcriptase mediates EMT through NF-κB signaling in tongue squamous cell carcinoma.

Authors:  Yan Wu; Chunxiang Bian; Chunlin Zhen; Liu Liu; Zhenghong Lin; Muhammad Farrukh Nisar; Mei Wang; Jörg W Bartsch; Enyi Huang; Ping Ji; Li Yang; Yanhong Yu; Junfeng Yang; Xuemei Jiang; Julia Li Zhong
Journal:  Oncotarget       Date:  2017-09-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.